Recent Progress in Development of Polo-Like Kinase 1 Inhibitors: Efforts So Far
Polo-like kinase 1(Plk1) plays an important role in the inhibition of cell proliferation and which is come under the family of serine/threonine-protein kinase. Which is a highly specific target for cancer therapy. In some clinical studies, Plk1 has been identified as a target for cancer. Currently,...
Main Authors: | Ramesh L. Sawant, Jyoti B. Wadekar, Rushikesh D. Ukirde, Ganesh D. Barkade |
---|---|
Format: | Article |
Language: | English |
Published: |
Tabriz University of Medical Sciences
2021-12-01
|
Series: | Pharmaceutical Sciences |
Subjects: | |
Online Access: | https://ps.tbzmed.ac.ir/PDF/ps-27-453.pdf |
Similar Items
-
Synthesis and evaluation of small molecule-based derivatives as inhibitors of polo-box domain of polo-like kinase-1
by: Yeo Kyung La, et al.
Published: (2023-11-01) -
Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors
by: Xue Zhi Zhao, et al.
Published: (2019-04-01) -
Synthesis, Molecular Docking and Anticancer Activity of Novel 1,3-Thiazolidin-4-Ones
by: Ramesh Sawant, et al.
Published: (2021-09-01) -
Structure-Based Virtual Screening and Biological Evaluation of Peptide Inhibitors for Polo-Box Domain
by: Fang Yan, et al.
Published: (2019-12-01) -
An investigation of Plk1 PBD inhibitor KBJK557 as a tumor growth suppressor in non-small cell lung cancer
by: Pethaiah Gunasekaran, et al.
Published: (2022-10-01)